SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 253.39 |
| Enterprise Value ($M) | 188.69 |
| Book Value ($M) | 438.87 |
| Book Value / Share | 5.20 |
| Price / Book | 0.58 |
| NCAV ($M) | 436.55 |
| NCAV / Share | 5.10 |
| Price / NCAV | 0.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.38 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 24.85 |
| Current Ratio | 24.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 462.36 |
| Assets | 464.67 |
| Liabilities | 25.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -132.22 |
| Net Income | -168.38 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -135.50 |
| Cash from Investing | 56.10 |
| Cash from Financing | 0.27 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Radoff Family Foundation | 3.30 | ||
| 13G/A | EcoR1 Capital, LLC | 4.00 | -38.59 | |
| 13D | BML Investment Partners, L.P. | 8.50 | 28.81 | |
| 13G/A | Fmr Llc | 7.84 | 23.69 | |
| 13G/A | Sommadossi Jean-Pierre | 9.60 | 9.20 | |
| 13G/A | Vanguard Group Inc | 5.51 | -24.47 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 63,953 | 340,011 | 18.81 | |
| 33,482 | 251,128 | 13.33 | |
| 22,073 | 124,871 | 17.68 | |
| 35,046 | 475,433 | 7.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ASMB – Assembly Biosciences, Inc. | ATHA – Athira Pharma, Inc. |
| ATRA – Atara Biotherapeutics, Inc. | AVXL – Anavex Life Sciences Corp. |
| BBIO – BridgeBio Pharma, Inc. |